Elevated CDCP1 correlates with aggressive disease and poor outcomes in multiple cancers, yet the upstream epigenetic mechanisms that establish and maintain CDCP1 expression in CRC are largely unexplored [18,19]. This evidence concerns the gene CDCP1 and colorectal carcinoma.